The Morgan Stanley team offered some updates on different sectors from their U.S. analysts - such as restaurants, where they say pricing is restrained and promotional activity high; and gaming and ...
If your mother dies and the mortgage is still outstanding, your brother and his wife's credit score will take a hit if they don't pay off the mortgage. Assuming it goes unpaid, the house will go into ...
Naturally, economists in 2025 would rather belong to the "Babson bailiwick" than the "Fisher fold." But is this rally really reminiscent of 1928? In one way, for sure: The laws of physics create a ...
Shares in BNP Paribas fell to a six-month low on Monday after the French bank lost a case linked to its alleged role in giving the Sudanese government access to international money markets during the ...
The push into domestic rare-earth minerals fits with the Trump administration's attempt to boost domestic production of the metals. Used in a range of products including consumer electronics, ...
Viridian Therapeutics reached a deal for up to $300 million in financing and accelerated the timelines for the submission of a biologics license application and topline data readouts from a late-stage ...
Telefonica Considering Closer Ties With 1&1, Including Potential Takeover, Handelsblatt Says, Citing Sources -- Spanish telecommunications group Telefonica is considering strengthening its cooperation ...
Shares of Replimune soared in premarket trading after the FDA accepted the biotechnology company's resubmission of a biologics license application for its treatment of advanced melanoma. The stock ...
Artec, a JV owned by Rheinmetall and KNDS Germany that produces armoured vehicles, received the order worth 3.41 billion euros ($3.97 billion) from European defense organization OCCAR, the company ...
Evercore's IT hardware and networking analyst Amit Daryanani has Apple at 'outperform' with a share price target of $290, citing the approaching earnings report as the main catalyst.
St. Louis Fed Chief Musalem Warns About Cutting Rates Too Much By Michael Maloney ...
Merck began construction on a previously announced $3 billion manufacturing facility in Elkton, Va., as the pharmaceutical industry, under pressure from the Trump administration, continues to invest ...